1-4 of 4
McKensie Collins
Close
Sort by
Journal Articles

Durable Multiplex Epigenetic Editing for Generation of Allogeneic CAR T without Chromosomal Rearrangements

Jamie Schafer, Justin Trombley, Benjamin Hallisey, Kunza Ahmad, Scott Clarkson, Thijs Udo, McKensie Collins, Laura Kehoe, Erica Hildebrand, Kaylie Schneider, Kuo-Chan Hung, Ricardo N Ramirez, Mary Morrison, Morgan Maeder, Sahar Abubucker, Ari Friedland, Pietro Spinelli, Vic Myer, Aron Jaffe
Journal: Blood
Blood (2023) 142 (Supplement 1): 3446.
https://doi.org/10.1182/blood-2023-179282
Published: 2023
Journal Articles

Co-Stimulatory Signaling Boosts CAR T Cell Efficacy Against CLL

Ziran Zhao, McKensie Collins, Clare Sun, Adrian Wiestner, J. Joseph Melenhorst
Journal: Blood
Blood (2022) 140 (Supplement 1): 10255–10256.
https://doi.org/10.1182/blood-2022-158614
Published: 2022
Journal Articles

B-CLL Mediated Resistance to CAR T Cell Therapy Via Insufficient Activation Is CAR-Independent

McKensie Collins, BS, Weimin Kong, PhD, Inyoung Jung, BS, Stefan M Lundh, BS, J. Joseph Melenhorst, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44.
https://doi.org/10.1182/blood-2020-137638
Published: 2020
Journal Articles

A Failure to Start: Aborted Activation of CAR T Cells in Chronic Lymphocytic Leukemia

McKensie Collins, BS, Weimin Kong, PhD, Inyoung Jung, BS, Meng Wang, BS, Stefan M Lundh, BS, Carl H June, MD, J. Joseph Melenhorst, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 681.
https://doi.org/10.1182/blood-2019-122063
Published: 2019